Bayer

FDA Received 6,000 Reports About Essure in 2018
FDA Received 6,000 Reports About Essure in 2018
Medical Devices and Diagnostics Industry
devices
FDA
Essure
Bayer
contraceptives
Flag link:
Bayer inks Arvinas deal to develop protein degraders
Bayer inks Arvinas deal to develop protein degraders
Fierce Biotech
Bayer
Arvinas
targeted protein degradation
Flag link:
Bayer's €8B animal health sale stirs up private equity shoppers: FT
Bayer's €8B animal health sale stirs up private equity shoppers: FT
Fierce Pharma
Bayer
animal health
M&A
CVC
Cinven
Permira
Flag link:
Bayer to work with Foundation Medicine on selecting cancer patients
Bayer to work with Foundation Medicine on selecting cancer patients
Reuters
Bayer
Foundation Medicine
Roche
cancer
Vitrakvi
genetic sequencing
Flag link:
Bayer’s Aliqopa gets speedy review for marginal zone lymphoma
Bayer’s Aliqopa gets speedy review for marginal zone lymphoma
Pharmaforum
Bayer
Aliqopa
FDA
breakthrough therapy
marginal zone lymphoma
Flag link:
Don't Overreact to the $2 Billion Punitive Damages Award Against Bayer
Don't Overreact to the $2 Billion Punitive Damages Award Against Bayer
Motley Fool
Bayer
California
Monsanto
Flag link:
Roche, Bayer unveil brain tumor data for NTRK inhibitors ahead of ASCO
Roche, Bayer unveil brain tumor data for NTRK inhibitors ahead of ASCO
BioCentury
Roche
Bayer
brain cancer
entrectinib
Vitrakvi
Flag link:
FDA Updates on Essure Postmarketing Study
FDA Updates on Essure Postmarketing Study
RAPS.org
Bayer
Essure
FDA
contraceptives
post-marketing studies
Flag link:
FDA approves Regeneron’s Eylea for diabetic retinopathy
FDA approves Regeneron’s Eylea for diabetic retinopathy
Pharmaforum
Regeneron
Eylea
diabetic retinopathy
FDA
Bayer
Flag link:
Bayer kicks off a $150M add-on for its campus in Berkeley
Bayer kicks off a $150M add-on for its campus in Berkeley
Endpoints
Bayer
drug manufacturing
Bay Area
Berkley
Flag link:
FDA tags Bayer's prostate cancer drug for priority review as drugmaker gears up against rivals
FDA tags Bayer's prostate cancer drug for priority review as drugmaker gears up against rivals
Endpoints
Bayer
Orion
prostate cancer
priority review
daralutamide
FDA
Flag link:
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Fierce Pharma
Bayer
JNJ
Xarelto
bloodthinners
Bristol-Myers Squibb
Pfizer
Eliquis
Flag link:
After revamping R&D in a global shakeup, Bayer prepping new labs for an expansion in cancer research at MIT
After revamping R&D in a global shakeup, Bayer prepping new labs for an expansion in cancer research at MIT
Endpoints
Bayer
R&D
layoffs
Cambridge MA
MIT
Flag link:
The top 15 pharma companies by 2018 revenue
The top 15 pharma companies by 2018 revenue
Fierce Pharma
JNJ
Roche
Pfizer
Novartis
Merck
GSK
Sanofi
AbbVie
Bayer
Eli Lilly
Amgen
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical
AstraZeneca
Flag link:
Bayer, after cyberattack, finds 'no evidence' hackers obtained data
Bayer, after cyberattack, finds 'no evidence' hackers obtained data
Fierce Pharma
Bayer
cyberattack
hacking
cybersecurity
Flag link:
Bayer posts early clinical data on follow-up to Loxo’s Vitrakvi
Bayer posts early clinical data on follow-up to Loxo’s Vitrakvi
Fierce Biotech
Bayer
Loxo Oncology
solid tumors
AACR
Flag link:
Bayer loses bid to toss some claims in Essure class action suit
Bayer loses bid to toss some claims in Essure class action suit
Mass Device
Bayer
Essure
devices
contraceptives
Flag link:
Bayer and J&J settle Xarelto lawsuits in US
Bayer and J&J settle Xarelto lawsuits in US
Pharmaforum
Bayer
JNJ
Xarelto
Flag link:
Bayer animal health sale could rake in $8B and bids from private equity: report
Bayer animal health sale could rake in $8B and bids from private equity: report
Fierce Pharma
Bayer
animal health
M&A
Flag link:
ACC 2019 preview – Bayer hopes for heart failure panache
ACC 2019 preview – Bayer hopes for heart failure panache
EP Vantage
Bayer
heart failure
Amarin
Esperion
ACC
Vascepa
bempedoic acid
Flag link:

Pages